← Open Payments lookup

WENHUI CAI: Open Payments

NPI 1679657910 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,205 in 39 payments from 12 companies in 2025. Trend: 2023 $9,657 · 2024 $680 · 2025 $9,205

Consulting: $6,888Travel & lodging: $1,169Food & beverage: $1,143Education: $5
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$8,611
Janssen Pharmaceuticals, Inc7$128
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$102
Janssen Scientific Affairs, LLC1$66
E.R. Squibb & Sons, L.L.C.2$52
Otsuka America Pharmaceutical, Inc.2$48
Alkermes, Inc.2$48
Teva Pharmaceuticals USA, Inc.2$46
Biogen, Inc.1$28
ABBVIE INC.1$28

Products named: INGREZZA, INVEGA SUSTENNA, CAPLYTA, COBENFY, AUSTEDO XR, REXULTI, ZURZUVAE, VRAYLAR.

Industry payments across AZ — which companies pay providers there.